Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
J Hematol Oncol
BDTX-189 is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations with Kd of 0
All LGK974-sensitive pancreatic cancer cell lines carried inactivating mutations of RNF43
Anti-breast cancer activity of LFM-A13
Smiles: O=C(COC1C=CC(Cl)=CC=1)N[C@@H]1CC[C@H](CC1)NC(=O)COC1C=CC(Cl)=CC=1
Cariprazine free base - CAS# 839712-12-8 size:10mg solid J Hematol OncolCariprazine free base, CAS No. 839712 12 8, also known as RGH 188 and MP 214, is an antipsychotic drug received FDA approval on September 17, 2015. Cariprazine acts as a D2 and D3 receptor partial agonist, with high selectivity towards the D3 receptor. Action on the dopaminergic systems makes it also potentially useful as an add on therapy in major depressive disorder. Cariprazine is approved for schizophrenia and bipolar disorder. It has also been
US$ 105.00
US$ 65.00
US$ 137.50
US$ 102.50
US$ 139.50
US$ 105.00
US$ 247.50